Triple-negative breast cancer (TNBC) is defined as a tumor that lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and HER2 (also known as ERBB2)2. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.